Braveheart Bio, Inc. carries a market capitalization of 1.50B, placing it among publicly traded companies globally.
| Market Cap | 1.50B |
| Enterprise Value | N/A |
Braveheart Bio, Inc.'s stock has gained approximately 18.16667% over the past 52 weeks. The 50-day moving average sits at 26.23, while the 200-day moving average is 26.23.
| Beta (5Y) | N/A |
| 52-Week Price Change | 18.16667% |
| 50-Day Moving Average | 26.23 |
| 200-Day Moving Average | 26.23 |
| Average Volume (20 Days) | N/A |